Investigation of racial differences in survival from non-small cell lung cancer with immunotherapy use: A Texas study

BACKGROUND: The use of immunotherapy is associated with improved survival among patients with Non-Small Cell Lung Cancer (NSCLC) and has gained widespread use in its management. However, there is limited information on whether the survival benefits associated with immunotherapy differ among races an...

Descripción completa

Detalles Bibliográficos
Autores principales: Olateju, Olajumoke A., Zeng, Zhen, Adenaiye, Oluwasanmi O., Varisco, Tyler J., Zakeri, Marjan, Sujit, Sansgiry S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869031/
https://www.ncbi.nlm.nih.gov/pubmed/36698397
http://dx.doi.org/10.3389/fonc.2022.1092355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869031/
https://www.ncbi.nlm.nih.gov/pubmed/36698397
http://dx.doi.org/10.3389/fonc.2022.1092355

Ejemplares similares